• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Take a Look at Cancer Therapeutic Products Currently on the Market and Those Under Development That Might Be Commercialized in the Near Future

Posted on: Thursday, 11 May 2006, 09:09 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c1431) has announced the addition of "Cancer Therapeutics Markets" to their offering.

This report provides in depth information on the developing market for anti-cancer products and services. It includes detailed market analyses and discussions of industry trends. It assesses the impact on the current and emerging anti-cancer product markets of available and emerging technologies. The report develops forecasts for anti-cancer based products to 2007. It discusses the efforts of biotechnology companies and pharmaceutical firms to incorporate new technologies for developing anti-cancer drugs into their corporate strategies.

This report examines cancer therapeutic products now on the market, as well as those currently under development that might be commercialized in the near future. The report also profiles a number of firms that are actively involved in the marketing and developing of products to be used in the treatment of cancer-both large multinational corporations, such as Bristol-Myers Squibb, Glaxo Wellcome, and Hoffmann-La Roche, and the smaller emerging biotechnology firms.

The report also provides an overview of the disease and data on cancers by site or type. It provides incidence and mortality data for different types of the disease. In addition, the report provides a summary of each of the therapies that are being used to treat cancer. Industry influences on the cancer therapeutic market are also discussed.

The scope of the study is worldwide. The overview section provides extended definitions of the anti-cancer drugs to provide the reader with a clear understanding of the technology involved. In addition, this section provides an analysis of how drugs that combat cancer will transform the health-care industry.

The company profiles section includes a detailed discussion of the companies that have pioneered anti-cancer drug development and examines how their available products and services are transforming the practice of medicine.

In this report more than 50 companies are discussed, and 15 of the most important companies with the largest and most active oncology discovery programs are examined in depth. The report focuses on how researchers are applying new approaches to drug discovery and development of anti-cancer compounds, and on how these technologies can be used most effectively and in a high-throughput capacity. Figures are based on revenue figures at the manufacturers' level and are projected at 2002-U.S. dollar value.

Companies mentioned:

-- AstraZeneca

-- Aventis

-- Bristol-Myers Squibb

-- Entremed

-- GlaxoSmithKline, plc

-- Genentech

-- Genta Incorporated

-- Ilex Oncology

-- Imclone Systems

-- ImmunoGen, Inc.

-- Eli Lilly & Company

-- NaPro Biotherapeutics

-- Novartis AG

-- Pharmacia Corporaton

-- Roche

-- Schering-Plough

-- Boehringer Ingelheim

-- OSI PHARMACEUTICAL

-- Abgenix

-- Sanofi-Synthelabo

-- Millennium Pharmaceuticals

For more information visit http://www.researchandmarkets.com/reports/c1431

Source: Business Wire

More News in this Category